Exercise or conversion by Paul Wotton of 2600 shares of Vericel Corp subject to Rule 16b-3

VCEL Stock  USD 57.64  0.28  0.48%   
About 54% of Vericel Corp's investor base is interested to short. The analysis of the overall investor sentiment regarding Vericel Corp Ord suggests that many traders are impartial. Vericel Corp's investing sentiment shows overall attitude of investors towards Vericel Corp Ord.
  
Filed transaction by Vericel Corp director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Vericel insider trading alert for exercise of common stock by Paul Wotton, the corporate stakeholder, on 28th of April 2023. This event was filed by Vericel Corp with SEC on 2023-04-28. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Vericel Corp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Vericel Corp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Vericel Corp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Vericel Corp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Vericel Corp Fundamental Analysis

We analyze Vericel Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Profit Margin

Profit Margin Comparative Analysis

Vericel Corp is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Vericel Corp Ord Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vericel Corp stock to make a market-neutral strategy. Peer analysis of Vericel Corp could also be used in its relative valuation, which is a method of valuing Vericel Corp by comparing valuation metrics with similar companies.

Peers

Vericel Corp Related Equities

CMRXChimerix   2.35   
0%
3.0%
CLGNCollplant Biotechnologies   1.53   
0%
2.0%
IPSCCentury Therapeutics   0.79   
0%
1.0%
RLAYRelay Therapeutics   0.00   
0%
0%
TERNTerns Pharmaceuticals   0.90   
1.0%
0%
CRNXCrinetics Pharmaceuticals   1.14   
1.0%
0%
CYTKCytokinetics   1.28   
1.0%
0%
XNCRXencor   1.35   
1.0%
0%
RVMDRevolution Medicines   1.46   
1.0%
0%
BPMCBlueprint Medicines   2.16   
2.0%
0%
PLRXPliant Therapeutics   2.18   
2.0%
0%
DAWNDay One   2.66   
3.0%
0%
STOKStoke Therapeutics   2.70   
3.0%
0%
MRUSMerus BV   3.22   
4.0%
0%
MREOMereo BioPharma   3.63   
4.0%
0%
XFORX4 Pharmaceuticals   3.95   
5.0%
0%
IDYAIdeaya Biosciences   4.19   
5.0%
0%
DYNDyne Therapeutics   6.37   
8.0%
0%
SNDXSyndax Pharmaceuticals   10.04   
13.0%
0%
RGNXRegenxbio   11.68   
15.0%
0%
KROSKeros Therapeutics   73.31   
100.0%
0%
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.045
Earnings Share
0.08
Revenue Per Share
4.685
Quarterly Revenue Growth
0.27
Return On Assets
(0)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.